These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6771065)

  • 1. Inhibition of prolactin secretion by nomifensine in man.
    Masala A; Alagna S; Devilla L; Delitala G; Rovasio PP
    Clin Endocrinol (Oxf); 1980 Mar; 12(3):237-41. PubMed ID: 6771065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomifensine decreases the thyroid-stimulating-hormone response to thyrotropin-releasing-hormone in normal subjects.
    Giusti M; Mazzocchi G; Mignone D; Tarditi W; Giordano G
    J Endocrinol Invest; 1983 Apr; 6(2):125-8. PubMed ID: 6408155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine suppression of TRH-stimulated prolactin and thyrotrophin release and accompanying inhibition of bromocriptine induced growth hormone release by TRH in normal man.
    Brown PM; Bacchus R; Sachs L; Sönksen PH; Wheeler M
    Clin Endocrinol (Oxf); 1979 May; 10(5):481-8. PubMed ID: 113143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of nomifensine to reduce serum prolactin levels in patients with hepatic encephalopathy.
    Masala A; Alagna S; Rovasio PP; Deplano A; Anania V; Chiandussi L; Langer M
    J Endocrinol Invest; 1985 Feb; 8(1):25-9. PubMed ID: 3921593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of suckling and of suckling followed by TRH or LH-RH on plasma prolactin, TSH, GH and FSH.
    Jeppsson S; Nilsson KO; Rannevik G; Wide L
    Acta Endocrinol (Copenh); 1976 Jun; 82(2):246-53. PubMed ID: 818858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of apomorphine on basal and TRH stimulated release of thyrotrophin and prolactin in man.
    Nilsson KO; Wide L; Hökfelt B
    Acta Endocrinol (Copenh); 1975 Oct; 80(2):220-9. PubMed ID: 809954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyproheptadine on thyrotrophin and prolactin secretion in normal man.
    Golstein J; Vanhaelst L; Bruno OD; L'Hermite M
    Acta Endocrinol (Copenh); 1979 Oct; 92(2):205-13. PubMed ID: 115197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of nomifensine on thyroid-stimulating hormone (TSH) in normal and hyperprolactinemic subjects.
    Giusti M; Mazzocchi G; Mignone D; Tarditi W; Contessini M; Bessarione D; Giordano G
    Neuroendocrinology; 1983 Dec; 37(6):406-10. PubMed ID: 6657002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nomifensine, an inhibitor of endogenous catecholamine re-uptake, in acromegaly, in hyperprolactinaemia, and against stimulated prolactin release in man.
    Scanlon MF; Gomez-Pan A; Mora B; Cook DB; Dewar JH; Hildyard A; Weightman DR; Evered DC; Hall R
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):191S-197S. PubMed ID: 911652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary hormone responses to hypothalamic releasing hormones in acromegaly.
    Cantalamessa L; Reschini E; Catania A; Giustina G
    Acta Endocrinol (Copenh); 1976 Dec; 83(4):673-83. PubMed ID: 826061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of somatostatin on thyrotropin, prolactin, growth hormone and insulin responses to thyrotropin releasing hormone and arginine in healthy, hypothyroid and acromegalic subjects.
    Faure N; Dussault JH; Nadeau A; Szots F; Guyda H; Labrie F
    Can Med Assoc J; 1977 Sep; 117(5):478-81. PubMed ID: 409475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
    Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin secretion in man following acute and long-term cimetidine administration.
    Masala A; Alagna S; Faedda R; Satta A; Rovasio PP
    Acta Endocrinol (Copenh); 1980 Apr; 93(4):392-5. PubMed ID: 7386109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced alterations of the hypothalamus-hypophysis axis.
    Mazzi C; Riva LP; Morandi G; Mainini E; Martinelli I; Bertaccini G
    Acta Psychiatr Belg; 1980; 80(5):619-37. PubMed ID: 7234453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of simultaneous administration of GHRH (1-40) and TRH on GH, PRL and TSH secretion in normal man.
    Giusti M; Lomeo A; Mazzocchi G; Torre R; Monachesi M; Sessarego P; Attanasio R; Giordano G
    J Endocrinol Invest; 1986 Dec; 9(6):497-501. PubMed ID: 3106459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotrophin, prolactin and growth hormone responses to TRH in barbiturate coma and in depression.
    Naeije R; Golstein J; Zegers De Beyl D; Linkowski P; Mendlewicz J; Copinschi G; Badawi M; Leclercq R; L'Hermite M; Vanhaelst L
    Clin Endocrinol (Oxf); 1978 Jul; 9(1):49-58. PubMed ID: 98247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum thyrotrophin, prolactin and growth hormone, response to TRH during oestrogen treatment.
    Rutlin E; Haug E; Torjesen PA
    Acta Endocrinol (Copenh); 1977 Jan; 84(1):23-35. PubMed ID: 401551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.
    Andreassen B; Huth J; Tyson JE
    Am J Obstet Gynecol; 1979 Nov; 135(6):737-42. PubMed ID: 115316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperthyroidism caused by a pituitary thyrotrophin-secreting tumour with excessive secretion of thyrotrophin-releasing hormone and subsequently followed by Graves' disease in a middle-aged woman.
    Kamoi K; Mitsuma T; Sato H; Yokoyama M; Washiyama K; Tanaka R; Arai O; Takasu N; Yamada T
    Acta Endocrinol (Copenh); 1985 Nov; 110(3):373-82. PubMed ID: 3934894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.